Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New vest-like device could map heart rhythm problems without needles

NCT ID NCT05772182

Diagnosis Sponsor: Corify Care S.L. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new non-invasive tool called ECG-Imaging that uses many electrodes on the body to create a 3D map of the heart's electrical activity. The goal was to see if it can more accurately locate the source of heart rhythm problems compared to a standard ECG. 362 participants who were already scheduled for an invasive heart procedure took part. The results will show whether this technology can help doctors plan treatments like ablation without needing as many invasive tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ACORYS MAPPING SYSTEM (ECG-Imaging device)
What this could lead to
If successful, this could give doctors a more accurate, non-invasive way to pinpoint the source of heart arrhythmias, potentially improving treatment planning.
What could go wrong
This is a completed diagnostic accuracy study, not a treatment trial. The new mapping system may not prove more accurate than standard methods in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

362 people

The number who actually took part.

Started

Dec 2022

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The patient's population will include those with an indication for an invasive electroanatomic study and/or intracardiac device implantation.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Indication for an invasive electroanatomic study and/or intracardiac device implantation. * Having obtained and signed the informed consent for study participation. * Ability to stand, to be able to obtain the 3D torso reconstruction necessary for the ECGI system. Exclusion Criteria: * \<18 years old * Inability to perform an endocardial catheterization and/or device implantation. * Physical or mental disability to understand and accept the informed consent. * Inability to stand to obtain the 3D torso reconstruction. * active coronary ischemia or decompensated heart failure * Intracardiac clot on trans-esophageal echocardiography * Pregnancy. * Disorganized arrhythmias (i.e. atrial fibrillation, polymorphic ventricular tachycardia).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac arrhythmia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac rhythm disease ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac arrhythmia

Contacts and locations

Locations

  • Hospital Clínic de Barcelona

    Barcelona, Barcelona, 08036, Spain

  • Hospital General Universitario Gregorio Marañón

    Madrid, Madrid, 28007, Spain

  • Hospital Universitari i Politècnic La Fe

    Valencia, Valencia, 46026, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.